This company listing is no longer active
La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Kazia Therapeutics Gestione
Gestione criteri di controllo 0/4
We currently do not have sufficient information about the CEO.
Informazioni chiave
John Friend
Amministratore delegato
AU$1.6m
Compenso totale
| Percentuale dello stipendio del CEO | 47.1% |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | less than a year |
| Durata media del Consiglio di amministrazione | 1.3yrs |
Aggiornamenti recenti sulla gestione
Recent updates
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Jun 24
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Feb 24We Take A Look At Why Kazia Therapeutics Limited's (ASX:KZA) CEO Compensation Is Well Earned
Nov 03We Think Kazia Therapeutics (ASX:KZA) Can Easily Afford To Drive Business Growth
Sep 23We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
May 04When Will Kazia Therapeutics Limited (ASX:KZA) Turn A Profit?
Mar 27Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?
Feb 28What Can We Learn About Kazia Therapeutics' (ASX:KZA) CEO Compensation?
Feb 01
We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
Jan 06Bullish: Analysts Just Made An Incredible Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts
Dec 11Kazia Therapeutics Limited (ASX:KZA): When Will It Breakeven?
Nov 26Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Jun 30 2023 | AU$2m | AU$743k | -AU$20m |
| Mar 31 2023 | n/a | n/a | -AU$23m |
| Dec 31 2022 | n/a | n/a | -AU$25m |
| Sep 30 2022 | n/a | n/a | -AU$25m |
| Jun 30 2022 | AU$1m | AU$430k | -AU$25m |
Compensazione vs Mercato: John's total compensation ($USD1.03M) is above average for companies of similar size in the Australian market ($USD295.83K).
Compensazione vs guadagni: John's compensation has increased whilst the company is unprofitable.
AMMINISTRATORE DELEGATO
John Friend (53 yo)
less than a year
Mandato
AU$1,576,913
Compensazione
Dr. John E. Friend, II, M. D., serves as Chief Executive Officer at Kazia Therapeutics Limited since May 01, 2023 and since August 1, 2023 serves as Managing Director and Director and served as Chief Medic...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Interim Chairman | less than a year | AU$1.58m | Nessun dato | |
| Chief Financial Officer | 1.8yrs | AU$1.05m | Nessun dato | |
| Company Secretary | less than a year | Nessun dato | Nessun dato |
0.8yrs
Durata media
Gestione esperta: KZA's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, MD & Interim Chairman | less than a year | AU$1.58m | Nessun dato | |
| Independent Non-Executive Director | 8.4yrs | AU$94.00k | 0.36% A$ 68.5k | |
| Member of Scientific Advisory Board | 1.3yrs | Nessun dato | Nessun dato | |
| Independent Non-Executive Director | 11yrs | AU$94.00k | 0.42% A$ 79.4k | |
| Director | less than a year | AU$7.12k | Nessun dato | |
| Member of Scientific Advisory Board | 1.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 1.3yrs | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | 1.3yrs | Nessun dato | Nessun dato |
1.3yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: KZA's board of directors are not considered experienced ( 1.3 years average tenure), which suggests a new board.